Compagnie Lombard Odier S Cm A Sangamo Therapeutics, Inc Transaction History

Compagnie Lombard Odier S Cm A

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$9.01 - $12.01 $90,100 - $120,100	-10,000 Closed	0 $0
Q2 2021 Jul 15, 2021	SELL	$10.17 - $12.64 $8.63 Million - $10.7 Million	-848,429 Reduced 98.84%	10,000 $120,000
Q1 2021 Apr 23, 2021	BUY	$10.88 - $17.05 $9.23 Million - $14.5 Million	848,429 Added 8484.29%	858,429 $10.8 Million
Q2 2018 Aug 10, 2018	BUY	$13.9 - $19.8 $139,000 - $198,000	10,000 New	10,000 $142,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.